Endpoints News 2026年6月4日 Novo Holdings backs European fund; Alnylam sends second obesity drug into clinic
Bruker 2026年6月4日 Is Bruker (BRKR) Quietly Recasting Its Moat Around Energy Transition And Biopharma Workflows? - simplywall.st
Bruker 2026年6月4日 Is Bruker (BRKR) Quietly Recasting Its Moat Around Energy Transition And Biopharma Workflows? - simplywall.st
Insilico Medicine 2026年6月4日 Insilico Medicine founder and CEO Alex Zhavoronkov recognized in inaugural SCW75 for pioneering AI-driven drug discovery and longevity research - EurekAlert!
Novo Nordisk 2026年6月4日 Veru Teams Up With Novo Nordisk for Obesity Combination Therapy Trial (VERU) - Yahoo Finance
PLoS Biology 2026年6月4日 Life Identification Numbers: A strain nomenclature approach to aid epidemiological surveillance of bacterial pathogens
PLoS Biology 2026年6月4日 Phenotypic heterogeneity optimizes trade-offs during adaptive deployment of the type VI secretion system
Eli Lilly 2026年6月4日 Pharmalittle: We're reading about fewer pharma investments in Germany, growing U.S. layoffs, and more - statnews.com
Lonza News 2026年6月4日 Stipple Bio Enters Multi-Target License Agreement with Lonza to Advance Precision Oncology ADC Therapies - The Manila Times
Lonza News 2026年6月4日 Stipple Bio Enters Multi-Target License Agreement with Lonza to Advance Precision Oncology ADC Therapies - The Manila Times
GE HealthCare 2026年6月4日 GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities - BioSpace
Science 2026年6月4日 Global extent and drivers of tree cover loss quantified with high-resolution satellite data | Science